Glaukos
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
CEOThomas William Burns
CEOThomas William Burns
Employees907
Employees907
HeadquartersAliso Viejo, California
HeadquartersAliso Viejo, California
Founded1998
Founded1998
Employees907
Employees907
GKOS Key Statistics
Market cap4.99B
Market cap4.99B
Price-Earnings ratio-35.78
Price-Earnings ratio-35.78
Dividend yield—
Dividend yield—
Average volume394.93K
Average volume394.93K
High today$100.60
High today$100.60
Low today$98.53
Low today$98.53
Open price$99.77
Open price$99.77
Volume288.90K
Volume288.90K
52 Week high$103.66
52 Week high$103.66
52 Week low$45.38
52 Week low$45.38
GKOS News
Simply Wall St 5d
Why Glaukos Corporation Could Be Worth Watching - Simply Wall StGlaukos Corporation ( ), is not the largest company out there, but it saw a double-digit share price rise of over 10% in the past couple of months on the NYSE....
Analyst ratings
67%
of 15 ratingsBuy
66.7%
Hold
33.3%
Sell
0%